by kdamaster | Aug 9, 2019 | Sedar
Thetford Mines, Quebec – August 7, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce that it has signed a letter of intent (“LOI”) with the shareholders of Consultandgrow Inc. (the “Shareholders”) on August 6, 2019 for the purchase of...
by kdamaster | Jul 31, 2019 | Sedar
Thetford Mines, Quebec – July 18, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the private placement previously announced in its press releases dated December 17, 2018 and March 21, 2019 has been completed with accredited...
by kdamaster | Jul 10, 2019 | Sedar
Thetford Mines, Quebec – June 26, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce that Dr. Giuseppe D’Aprano is appointed to the Corporation’s management team as Chief Scientific Officer (CSO) as of June 26, 2019. VIEW THE...
by kdamaster | Feb 18, 2019 | Sedar
Thetford Mines, Quebec – February 18, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the transaction with Strides Pharma Canada inc. (“Strides”) previously announced in its press releases dated December 4, 2018 and February...
by kdamaster | Feb 1, 2019 | Sedar
Thetford Mines, Quebec – February 1st, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce, as previously disclosed in its press release dated December 4, 2018, that it has entered into a share purchase agreement (the “Purchase...
by kdamaster | Dec 4, 2018 | Sedar
Thetford Mines, Quebec – December 4, 2018 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce that it has signed a letter of intent (“LOI”) with Strides Pharma Global Pte Ltd. (“Strides”) for the sales of a majority stake in Pharmapar Inc....
Recent Comments